Nirmatrelvir (PF-07321332) is an Orally Active SARS-CoV 3CLpro Inhibitor for COVID-19 Research
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-19 pandemic. Firstly, the coronavirus 3-chymotrypsin-like protease (3CLpro) can control virus replication. Secondly, 3CLpro is responsible for cleaving…